News About Laboratory Services


Cerba/Lancet JV to expand

Cerba is set to expand its JV with pan-African lab network Lancet into more French-speaking countries.

How consolidated is the lab market?

Everybody in the lab sector likes to talk about how much it is consolidated across Europe. This week's infographic assesses that claim: it shows that over half the market is still owned by players with less than €100m revenues and only 15.5% by its top two players. 

Metropolis kicks off IPO, targets $175m

Indian lab group Metropolis kicked off its IPO yesterday (Wednesday, April 3). It hopes to raise Rs 1,200 crore ($175m). We speak to an India-based market expert about the move.

From factory to decision support engine

We interview Claudia Pronk, CEO of Atalmedial, one of the largest Dutch diagnostic lab with a network of more than 100 outpatient clinics and collection locations, about its journey to providing doctors with very detailed, actionable diagnoses and also about the Dutch market.

Profit and revenue up at IDH despite challenging environment

LSE-listed Integrated Diagnostics Holdings (IDH) has released its full-year results showing substantial growth in profits, revenue and EBITDA. The lab group, which was brought to IPO by CEO Hend el Sherbini in 2015 and is present in Egypt, Jordan, Sudan and Nigeria, has added an additional 40 branches to its network in the last year, […]

10% of French labs consolidated in 2018

Over half of France's laboratory sites now belong to the market's seven biggest players after rapid M&A activity saw 10% of all sites consolidated in 2018. More deals are on the horizon.

Diagnostyka partners with symptom checker

CEE's largest lab company Diagnostyka has partnered with digital symptom checker Infermedica in a bid to capture patient flows and leverage the data it collects.

Is Citilab in decline?

Russian lab group Citilab, once the second largest player on the market, has apparently seen a drop in revenue over the past three years. HBI investigates.

Major shake up of UK lab market expected by 2021

HBI understands a quarter of the UK's pathology outsourcing contracts - and at least a half of its revenue - could switch hands over the next two years, which could potentially see a major shake-up of the market share among the top players.

Find Us